Target : Using the geriatric evaluation to predict mortality, functional prognosis and quality of life after percutaneous implanting an aortic prosthetic valve in patients over 75.

Trial date : 2015

Number of patients : 500

Source of funding : Public (AOM)

Centers participating : 14 TAVI implantation centers and 13 geriatric centers in France

STATUT